Peripheral blood lymphocytes and platelets are prognostic in surgical pT1 non-small cell lung cancer.
There is a paucity of prognostic factors for patients with stage I non-small cell lung cancer (NSCLC) undergoing surgery. We aimed to investigate the prognostic role of preoperative complete blood count in patients with stage I NSCLC patients undergoing surgery. A retrospective chart review was performed of patients who underwent surgery for Stage I NSCLC between 2000-2015. Patients who died within 30 days of surgery were excluded. Primary end-point was recurrence. Preoperative complete blood count values were analyzed, and a median value was used as cut-off. Statistical analysis utilized chi-squared and t-tests, along with univariate and multivariate analyses via Cox regression modeling. In total, 103 patients were included. High lymphocyte was significantly associated with recurrence (5-year recurrence-free survival [RFS] of 69.8% for high vs 95.7% for low, p=0.003), as well as high platelet (5-year RFS of 72.0% for high vs 91.8% for low, p=0.02). On multivariate analysis, high lymphocyte and platelet were independent prognostic factors ([HR 7.27, p=0.005], [HR 7.49, p=0.003]) as well as tumor and treatment characteristics ([HR 5.40, p=0.008], [HR 4.59, p=0.01]). Among patients with pT1 lesions, high lymphocyte and high platelet remained independent prognostic factors ([HR 8.41, p=0.03], [HR 19.78, p=0.004]). Neither NLR nor PLR were significantly associated with recurrence. In patients with pathologic stage I NSCLC undergoing surgical resection, preoperative blood count from peripheral blood may provide prognostic value. Of significance, in patients with pT1N0 NSCLC, high lymphocyte count and high platelet count were associated with higher recurrence.